AYMAN DAOUD
Clinical Neurophysiology Physician in CHESTERFIELD, Missouri. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
AYMAN DAOUD reported a CMS MIPS final score of 89.2387/100 — above the 83.1 national average — and filed 2,814 Medicare Part D claims in 2023.
- 89.2387/100
- MIPS score · +6 vs avg
- 3K
- Part D claims, 2023
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
AYMAN DAOUD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
89 Top 42% higher than 58% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
AYMAN DAOUD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about AYMAN DAOUD?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Missouri
How Clinical Neurophysiology Physician compares to other specialties among Missouri providers
Clinical Neurophysiology Physician share within Missouri
Clinical Neurophysiology Physician is one of the more visible NUCC categories in Missouri
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
AYMAN DAOUD's 2023 MIPS final score plotted against the Clinical Neurophysiology Physician national average
- MIPS Final Score
- 89.2387/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Clinical Neurophysiology Physician) — 89.2387/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Clinical Neurophysiology Physician US NPIs
89.2387/100 MIPS final score — 6.1 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Clinical Neurophysiology Physician. Quality dim: 84.1405.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
AYMAN DAOUD appears in the CMS NPPES registry as a Clinical Neurophysiology Physician provider at 111 SAINT LUKES CENTER DR STE 20B, CHESTERFIELD, MO, 63017, with a listed phone of (636) 685-7745. NPI 1487013512 was issued on 02/17/2016. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what DAOUD most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 2,814 prescription claims written by this provider, covering 515 Medicare beneficiaries and totaling roughly $306K in drug spend. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 89.2387/100 for the 2023 performance year (Quality 84.1405), compared with the national average of 83.1.
Clinical Neurophysiology Physician is a narrow specialty nationwide, with 639 enrolled providers across 50 states and an average of 1,523 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1487013512 |
|---|---|
| Specialty | Clinical Neurophysiology Physician |
| Gender | Male |
| NPI Issued | 02/17/2016 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm AYMAN DAOUD's current license status, disciplinary history, and board certifications with the Missouri Board of Registration for the Healing Arts in Missouri before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Alternative Payment Model
Hospital and facility affiliations
Facilities where AYMAN DAOUD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for AYMAN DAOUD. Source: openpaymentsdata.cms.gov.
Total received
$3.1K
Largest payer
ABBVIE INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 5,007
- Total Day Supply
- 146,837
- Generic Drug Cost
- $146K
Patient Demographics
- Average Patient Age
- 74.3 years
- Avg HCC Risk Score
- 1.50
- Gender Split
- 55% female / 45% male
- Age Distribution
- <65: 50, 65-74: 191, 75-84: 211, 85+: 63
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What AYMAN DAOUD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Gabapentin
Gabapentin
356 claims
- Carbidopa-Levodopa
Carbidopa-Levodopa
337 claims
- Memantine Hcl
Memantine Hcl
253 claims
- Pregabalin
Pregabalin
181 claims
- Primidone 116
Primidone
116 claims
- Donepezil Hcl 98
Donepezil Hcl
98 claims
- Nortriptyline Hcl 90
Nortriptyline Hcl
90 claims
- Lacosamide 87
Lacosamide
87 claims
| Drug | Claims |
|---|---|
| Gabapentin | 356 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 337 |
| Memantine Hcl | 253 |
| Pregabalin | 181 |
| Primidone | 116 |
| Donepezil Hcl | 98 |
| Nortriptyline Hcl | 90 |
| Lacosamide | 87 |
| Levetiracetam | 82 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 72 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Clinical Neurophysiology Physician Overview
How AYMAN DAOUD fits within the Clinical Neurophysiology Physician landscape nationally.
AYMAN DAOUD's 2,814 claims are above the specialty average of 1,523.
Nearby Clinical Neurophysiology Physician Providers in Missouri
Other clinicians with the same primary specialty enrolled in Missouri, drawn from the same CMS NPPES roster as DAOUD.
Compare Clinical Neurophysiology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Missouri
Frequently Asked Questions
What is AYMAN DAOUD's specialty? ▼
How much does AYMAN DAOUD prescribe under Medicare Part D? ▼
What is AYMAN DAOUD's Medicare quality score? ▼
Where is AYMAN DAOUD located? ▼
What is AYMAN DAOUD's NPI number? ▼
How many Clinical Neurophysiology Physician providers are there in the US? ▼
What drugs does AYMAN DAOUD prescribe most often? ▼
Does AYMAN DAOUD accept Medicare? ▼
How can I verify AYMAN DAOUD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology